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Objective: To evaluate the effectiveness of submandibular duct relocation (SMDR)
in drooling children with neurological disorders.
Design: Prospective cohort study.
Setting: Academic Outpatient Saliva Control Clinic.
Participants: Ninety‐one children suffering from moderate to severe drooling.
Main outcome measures: Direct observational drooling quotient (DQ; 0‐100) and
caretaker Visual Analogue Scale (VAS; 0‐100). Secondary outcome measures were
drooling severity (DS) and frequency rating scales.
Results: The DQ at baseline, 8 and 32 weeks postoperatively was 26.4, 12.3 and
10.8, respectively. VAS score decreased from 80.1 at baseline to 28.3 and 37.0 at 8
and 32 weeks after surgery. Median DS at baseline, 8 and 32 weeks was 5, 3 and
4, whereas the drooling frequency median scores were 4, 2 and 2, respectively. Five
children required prolonged intubation due to transient floor of the mouth swelling,
two of whom developed a ventilator‐associated pneumonia. Another child devel-
oped atelectasis with postoperative pneumonia. Two more children needed tube
feeding because of postoperative eating difficulties for 3 days or suprapubic
catheterisation for urinary retention. Children aged 12 years or older (OR = 3.41;
P = 0.03) and those with adequate stability and position of the head (OR = 2.84;
P = 0.09) appeared to benefit most from treatment.
Conclusions: Submandibular duct relocation combined with excision of the sublin-
gual glands appears to be relatively safe and effective in diminishing visible drooling
in children with neurological disorders, particularly in children aged 12 years and
older and those without a forward head posture.
1 | INTRODUCTION
Drooling is generally caused by an inability to swallow saliva effec-
tively rather than by an excessive production of saliva.1,2 Excessive
drooling is considered to be abnormal in children older than age four.
It is common among neurologically disabled children, and up to 60%
of children with cerebral palsy have complaints of drooling.3-5 It can
lead to multiple personal and social consequences, such as difficulties
in making friends and exclusion by peers; in severe cases, it may lead
to social isolation. Medical complications include a higher risk of skin
infections, choking, aspiration, pneumonia and feeding or speech
problems. Excessive drooling may also interfere with the child's daily
care and rehabilitation therapies, creating an additional burden.6
A vast array of different therapies has been used to treat chil-
dren with excessive drooling. These options include behavioural and
non‐medical interventions, anticholinergic medications, botulinum
toxin injection into the salivary glands and surgery.7 Evidence for the
effectiveness of these treatments in drooling children is scarce and
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(inter)nationally accepted guidelines are lacking. So far, various surgi-
cal approaches have been implemented.8 In our centre we have
established a multidisciplinary approach for drooling children. The
most commonly applied surgical procedure in our centre is bilateral
submandibular duct relocation (SMDR). By relocating the papillae of
the submandibular ducts from the anterior oral cavity to the base of
the tongue, saliva from the submandibular glands is able to flow
directly into the oropharynx and triggers the pharyngeal swallow
reflex immediately. Simultaneous excision of the sublingual glands
reduces the risk of ranula formation.9 In children with an impaired
pharyngeal phase of swallowing SMDR is considered contraindicated
because of the risk of aspiration.
Earlier studies suggest that SMDR is effective and safe.9-12 Most
studies performed so far, however, were small retrospective case
series, that used subjective instead of objective outcomes. Further-
more, these studies showed that SMDR was not effective in all chil-
dren. For more clarity, we formed this prospective cohort to study
the effectiveness of SMDR, and tried to identify children that benefit
more or less from this procedure.
2 | METHODS
2.1 | Ethical considerations
The present study was conducted in accordance with national and
international ethical standards. Informed consent was obtained
before each surgery by parents or caregivers.
2.2 | Patients
We performed a cohort study between March 2005 and December
2014. All 91 children and adolescents with excessive drooling who
underwent SMDR were evaluated by our multidisciplinary team at
the Radboud University Medical Centre, consisting of a speech and
language therapist, otolaryngologist and a pediatric neurologist. All
patients had a diagnosis of cerebral palsy or another non‐progressive
developmental disability. All participants were between 6 and
24 years of age at the time of enrolment, were considered to have a
safe pharyngeal phase of swallowing and had at least moderate
drooling, intermittent throughout the day. Fifty‐six patients were
treated with Botulin toxin injections prior to surgery. None of the
participants had undergone previous surgical procedures for saliva
control and no additional anticholinergic medication or Botulinum
toxin injections were allowed during this study.
2.3 | Procedure
Surgery was performed under general anaesthesia. After the papillae
of the submandibular ducts were located, the floor of the mouth was
infiltrated with Prilocaine and Adrenaline, and an incision was made to
create two mucosal islands containing the papilla. The submandibular
duct was freed anterior to posterior, taking special care to prevent
damage to the lingual nerve. The sublingual glands were resected
bilaterally to prevent ranula formation. After submucosal re‐routing of
the submandibular ducts to the oropharynx, the papillae were sutured
at the base of the tongue with a single stitch, posterior to the glos-
sopharyngeal plica. Children were given a single dose of corticos-
teroids during surgery and, if necessary, a second dose on the first
postoperative day. We routinely prescribed a 7‐day postoperative
course of antibiotics (co‐amoxiclav) with a 5‐day period of diclofenac
for pain management.13 All children were admitted to an intensive
care unit for 24 hours after surgery and stayed intubated to prevent
airway obstruction problems in case of swelling of the floor of the
mouth.
2.4 | Outcome measures
Primary outcome measures in this study were the drooling quotient
(DQ) and a Visual Analogue Scale (VAS) score.
The DQ is a validated, direct‐observational semi‐quantitative
objective method to assess the severity of drooling.14 It is defined as
the percentage of time a person drools and was measured by specially
trained speech and language therapists. During two 5‐minute sessions
(one while the participants were concentrating and one while they
were distracted) the absence or presence of new saliva on lip or chin
was recorded every 15 seconds.15 Participants were evaluated stan-
dardised at least 1 hour after a meal while awake and sitting erect. A
caretaker VAS score, indicating the subjective drooling severity (DS)
over the previous 2 weeks, was marked on a 10 cm‐line, with 100 cor-
responding to severe drooling and zero to no drooling. A clinically rele-
vant response to treatment was defined as ≥50% reduction in DQ or a
reduction of ≥2 SDs in VAS score.16,17 Secondary subjective outcome
measures were drooling frequency (never, mild, moderate, severe, pro-
fuse; DF) and drooling severity (no, occasionally, frequently, constant;
DS) for which we used the DF and DS rating scales introduced by Tho-
mas‐Stonell and Greenberg.18
2.5 | Statistical analysis
To study the effectiveness of SMDR we compared the DQ, VAS, DF
and DS scores at baseline with the scores after 8 and 32 weeks
using either a paired sample t test or a Wilcoxon rank. We per-
formed logistic regression analyses to study which factors are associ-
ated with a better treatment outcome, which was defined as at least
a 50% reduction in DQ 32 weeks after treatment. We calculated
Keypoints
• The first study to investigate submandibular BoNT-A
injections as predictor of SMDR outcome in drooling.
• Submandibular BoNT-A injection effect does not predict
SMDR outcome.
• Submandibular duct relocation is more effective and
more permanent than BoNT-A injection
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odds ratios and their 95% confidence intervals. Factors univariable
associated with outcome (P‐value was set at <0.10 at which a rela-
tionship to outcome could be considered as biologically plausible)
were included in a multivariable logistic regression analysis. To
reduce bias and to increase statistical efficiency, we imputed the
missing data using the linear regression multiple imputation method
available in SPSS. All statistical analyses were performed using SPSS
20.0 for Windows (SPSS Inc, Chicago, IL, USA).
3 | RESULTS
Between March 2005 and December 2014 91 children and adoles-
cents underwent SMDR in our centre. Of the 91 included children,
61 were boys and 30 were girls. The mean age at surgery was
15 years (SD 4 years; range 6‐24 years). Most children were diag-
nosed with cerebral palsy (70.3%). About half of the children with
CP had a Gross Motor Function Classification System score of 4 or
higher, which meant they were wheelchair‐bound. Table 1 shows the
baseline demographic characteristics.
3.1 | Primary outcome measures
At baseline the mean DQ was 26.4 (95% CI 24.7‐28.1). After 8 and
32 weeks, it was 12.3 (95% CI 11.1‐13.5), and 10.8 (95% CI 9.4‐12.1),
respectively. See also Figure 1. Thirty‐nine of the total of 273 DQ
scores were missing (14.3%). Sixty children (66.0%) experienced a 50%
reduction in DQ score at 32 weeks and were regarded as responders.
At baseline, 8 and 32 weeks the mean VAS scores were 80.7
(95% CI 79.6‐81.8), 28.3 (95% CI 26.3‐30.3) and 37.0 (95% CI 34.5‐
39.4), respectively. Twenty‐nine of the total of 273 VAS scores were
missing (10.6%). Sixty‐seven children (73.6%) had a reduction of
2 SD in VAS score at 32 weeks.
3.2 | Secondary outcome measures
Figure 2 shows the distribution of DS scores at baseline, 8 and
32 weeks after surgery. Wilcoxon rank tests showed a significant
decrease between baseline and 8 weeks as well as between baseline
and 32 weeks after surgery (P < 0.001). At baseline and 32 weeks
after surgery 72.5% and 20.9%, respectively, had profuse drooling;
at 32 weeks the majority of patients experienced moderate (28.6%)
or severe drooling (31.9%). Thirty‐one of the total of 273 DS scores
were missing (11.4%).
Figure 3 shows the distribution of DF scores. The baseline med-
ian DF score declined from 60.4% constant drooling at baseline to
7.7% after 32 weeks, at which time the majority of the participants
only drools occasionally (52.7%). Thirty‐two of the total of 273 DF
scores were missing (11.7%).
TABLE 1 Demographic data
No. patients (valid %)
N = 91
Gender
Male 61 (67.0)
Female 30 (33.0)
Age
<12 y 21 (23.1)
≥12 y 70 (76.9)
Mean (range) 15.0 (6‐24)
Diagnosis
Cerebral palsya
Bilateral paresis 60 (65.9)
Unilateral paresis 4 (4.4)
Other neurodevelopmental
disabilities
27 (29.7)
GMFCS level (N = 64)
I 3 (4.7)
II 8 (12.5)
III 19 (29.7)
IV 21 (32.8)
V 13 (20.3)
Epilepsy
Controlled 41 (45.1)
Intractable 15 (16.5)
No epilepsy 35 (38.5)
Developmental age
<4 y 47 (51.6)
4‐6 y, IQ < 70 17 (18.7)
4‐6 y, IQ > 70 3 (3.3)
>6 y 17 (18.7)
Unknown 7 (7.7)
GMFCS, Gross Motor Function Classification System, only applicable for
children with cerebral palsy; I, able to walk; IQ, intelligence quotient; V,
impaired in all areas of motor function.
aConfirmed by a paediatric neurologist.
F IGURE 1 Subjective Visual Analog Scale (VAS) scores and
drooling quotient (DQ), mean in time (N = 91)
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3.3 | Subgroups
A 50% reduction in DQ was considered a clinically relevant
improvement. At 32 weeks 60 children (66.0%) experienced a 50%
reduction in DQ score. Three patients (3.3%) had a DQ of zero
both pre and postoperatively; they were considered as non‐respon-
ders in the statistical analysis, even though two of them expressed
satisfaction with the procedure. By analogy with Erasmus et al19, in
this study 11 patient characteristics (Table 2) were considered to be
possible variables associated with treatment response based on bio-
logical plausibility. They were analysed by logistic regression. Uni-
variable logistic regression analysis showed that children with
adequate head stability and those aged 12 years or older benefited
the most from surgery (P < 0.10). Multivariable logistic regression
with these two factors supported these results, with a significantly
better outcome for children above 12 years of age (OR = 3.41;
P = 0.03) and a trend towards children without anterior flexion of
the head (OR = 2.84, P = 0.09). Table 3 shows the distribution of
success rates among patients according to age and/or head stability.
Success rates are highest in children older than 12 years with an
adequate head stability (78%). Success rates are lowest in children
younger than 12 years without adequate head stability (18%), this
group only includes 11 children.
3.4 | Adverse events
The mean surgical time was 93 minutes, with a mean duration of
hospital stay of 4.40 days (range 2‐11). Five children experienced
transient swelling of the floor of the mouth, which required pro-
longed intubation; two of them developed ventilator‐associated
pneumonia. One child had postoperative eating difficulties and
received tube feeding for 3 days. One child developed an atelectasis
and postoperative pneumonia. One child experienced urinary reten-
tion postoperatively, which required suprapubic catheterisation.
None of the children suffered from ranulas.
4 | DISCUSSION
4.1 | Synopsis of key/new findings
Our results show that bilateral SMDR with excision of the sublingual
glands appears to be an effective treatment for drooling. Objective
and subjective measurements improved significantly after surgery.
The majority of patients improve from frequent or constant drooling
to occasional drooling, and they drool less severely. Children aged
12 years or older and those with an adequate head stability
appeared to benefit most from this treatment.
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4.2 | Strengths and limitations of the study
Strengths of our study include the analysis of prospectively collected
data of both subjective and objective measurements to evaluate the
effect of this procedure. With pre and postoperative assessments,
we could evaluate change over time. In addition, we identified sub-
groups, which could benefit most from this intervention. Using multi-
ple imputation we established the best way to deal with missing
values. Some potential limitations should also be mentioned. First,
we used no control group as this is a cohort study and the range of
ages is also quite wide in our study. Second, data in the present
study were collected in one clinic in one country. Despite this we
expect that results might be generalisable because the patients’
characteristics and a surgical procedure are comparable to others.
4.3 | Comparisons with other studies
The results of the present study are in agreement with previous
research.9-11 Former studies have predominantly focused on subjec-
tive postoperative satisfaction, often without preoperative assess-
ment. To date Crysdale et al20 evaluated the largest group (n = 106)
with data on patient satisfaction. In that study, preoperative drooling
VAS score of 8.1 (on a scale to 10) had decreased to 4.9 after a mean
follow‐up of 4 years. Although subjective measurements are an impor-
tant evaluation tool objective measurements are necessary to evaluate
interventions properly. There are some studies on surgery that use
objective methods. Ekedahl et al21 measured a significant decrease in
drooling by intravenously administered radioactive isotopes. Webb et
al22 used the DQ in 28 patients and in his study the measured DQ of
50.0 at baseline decreased after surgery to 12.3. With our present
study we show a significant decrease in the severity of drooling post-
operatively in objective as well as subjective measurements.
4.4 | Clinical applicability of the study
This study demonstrated a possibly favourable outcome in children with
adequate head stability. Contrary to other surgical procedures such as
extirpation of the submandibular glands, the amount of produced saliva
is not markedly reduced after SMDR. It is therefore possible that in chil-
dren with poor posture control and incomplete lip closure, saliva can
still re‐enter the oral cavity and cause drooling.23 In such cases sub-
mandibular gland excision is possibly more effective than SMDR.
In this study children older than 12 years benefit more from
SMDR. We have no adequate explanation for this. It could be because
of further development of oral cavity function and/or head stability.
There could also have been a selection bias in which children with
worse drooling visited our outpatient clinic earlier and received earlier
surgery. The age at which this procedure is performed in these chil-
dren varies throughout literature. There are centres where this proce-
dure is performed from 4 or 5 years of age.9-12,24,25 Based on our
results, assuming saliva control will improve with ongoing develop-
ment and the risks that are involved in this surgery, in general we rec-
ommend SMDR after the age of 12 years.
TABLE 2 Variables negatively contributing to treatment response
Clinical
characteristic
Univariable analyses Multivariable analyses
OR (95% CI)
P
value
Adjusted OR
(95% CI)
P
value
Male 1.57 (0.35‐7.08) 0.54 – –
Age <12 y 3.67 (1.28‐10.55) 0.02 3.41 (1.12‐10.38) 0.03
Cerebral palsy 1.19 (0.45‐3.15) 0.73 – –
GMFCS level
IV‐V
0.78 (0.25‐2.42) 0.67 – –
Epilepsy 1.28 (0.43‐3.79) 0.65 – –
Developmental age
<4 y or 4‐
6 y, IQ < 70
1.43 (0.46‐4.44) 0.54 – –
BTX therapy
previously
0.45 (0.16‐1.26) 0.13 – –
Ante flexion
head position
3.03 (0.93‐9.84) 0.06 2.84 (0.84‐9.63) 0.09
Abnormal lip
closure
0.62 (0.24‐1.58) 0.32 – –
Tongue
protrusion
0.70 (0.22‐2.20) 0.53 – –
Abnormal
tongue
movements
1.59 (0.41‐6.11) 0.49 – –
BTX, botulium toxin; CI, confidence interval; GMFCS, Gross Motor Func-
tion Classification System; IQ, intelligence quotient; OR, odds ratio.
All variables were dichotomous (0 or 1). P value ≤0.05 indicates statisti-
cal significance.
TABLE 3 Distribution of success rates according to age and/or
head stability
Characteristic
Baseline
(N)
Responder
(N)
Non‐
responder
(N)
Success
rates DQ
32 wk, %
Age
<12 y 21 9 12 42.9
≥12 y 70 51 19 72.9
Head position
Inadequate
head
stability
(IHS)
40 21 19 52.5
Adequate
head
stability
(AHS)
51 39 12 76.5
Combination
<12 y + IHS 11 2 9 18.2
≥12 y + IHS 29 39 10 65.5
<12 y + AHS 10 7 3 70.0
≥12 y + AHS 41 32 9 78.0
DQ, drooling quotient.
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Extensive floor of the mouth surgery, as in SMDR, might lead to
extensive swelling of the floor of the mouth or tongue. The resulting
airway obstruction may necessitate intubation that can be very diffi-
cult and challenging in a distressed and neurological disabled child.
In our study five children experienced swelling of the floor of the
mouth which required prolonged intubation. To avoid this risk we
prefer and advise to keep these children intubated for 12‐24 hours
after surgery. Before extubation an inspection of the tongue and
floor of the mouth should be performed.
Submandibular duct relocation is the most commonly performed
surgical procedure to treat anterior, visible drooling in our centre in
children with adequate pharyngeal swallow function. There are no
external scars and saliva production is mostly preserved. In young
children botulinum toxin treatment could bridge the time until a
child is old enough to endure surgery. This has been previously sug-
gested.13 Botulinum toxin injections are less invasive, no hospitalisa-
tion is needed and they are effective in approximately 50% of the
patients.17 However, their effect is generally temporary and it could
require repeated general anaesthesia. Therefore, in older children
more definitive solution is favourable. In case of saliva aspiration or
when the pharyngeal phase of swallowing is likely to worsen over
time due to the underlying cause, SMDR is contra‐indicated. In
these cases we recommend a treatment which reduces the amount
of saliva produced instead of relocating the saliva to lower the risk
of aspiration.
In conclusion, our study supports that SMDR is a safe and effec-
tive method to reduce visible drooling without saliva aspiration in
neurological disabled children. An age under 12 years and decreased
head stability negatively influence outcome of surgery. We recom-
mend considering other treatment options, in case of age <12 years
botulinum toxin injections could bridge to an older age and in obvi-
ous head instability surgical treatments like submandibular extirpa-
tion or ligation of the submandibular ducts could be used.
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